FDA Approves New Flu Treatment
AAFA COMMUNITY SERVICES · 10/24/183:00 PMToday, the U.S. Food and Drug Administration ap-proved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12
years of age and older who have been symptomatic
January 5, 2019 – 4:00 PM Eastern
What You Need to Know to Improve Asthma Adherence Dr. Weinstein will be presenting research-
based practical strategies to help improve asthma patient adherence and outcomes.